Cypress Wealth Services’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $152K | Hold |
|
|||||
|
2025
Q2 | $179K | Hold |
|
|||||
|
2025
Q1 | $150K | Hold |
|
|||||
|
2024
Q4 | $150K | Hold |
|
|||||
|
2024
Q3 | $152K | Hold |
|
|||||
|
2024
Q2 | $124K | Hold |
|
|||||
|
2024
Q1 | $102K | Hold |
|
|||||
|
2023
Q4 | $120K | Hold |
|
|||||
|
2023
Q3 | $142K | Hold |
|
|||||
|
2023
Q2 | $144K | Hold |
|
|||||
|
2023
Q1 | $167K | Hold |
|
|||||
|
2022
Q4 | $230K | Hold |
|
|||||
|
2022
Q3 | $273K | Hold |
|
|||||
|
2022
Q2 | $212K | Hold |
|
|||||
|
2022
Q1 | $325K | Hold |
|
|||||
|
2021
Q4 | $277K | Hold |
|
|||||
|
2021
Q3 | $287K | Hold |
|
|||||
|
2021
Q2 | $316K | Hold |
|
|||||
|
2021
Q1 | $203K | Hold |
|
|||||
|
2020
Q4 | $149K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $48K | Hold |
|
|||||
|
2020
Q1 | $20K | Buy |
|